Leadless Cardiac Pacing: New Horizons.
Leadless
Pacemaker
Pacing
Technology
Journal
Cardiology and therapy
ISSN: 2193-8261
Titre abrégé: Cardiol Ther
Pays: England
ID NLM: 101634495
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
08
09
2022
accepted:
31
10
2022
pubmed:
24
11
2022
medline:
24
11
2022
entrez:
23
11
2022
Statut:
ppublish
Résumé
Since the introduction of transvenous cardiac pacing leads, pacemaker system design has remained similar for several decades. Progressive miniaturisation of electronic circuitry and batteries has enabled a smaller, single pacing unit comprising the intracardiac electrodes, generator and computer. This review explores the development of leadless pacing, the clinical trials comparing leadless to transvenous pacing in addition to the future developments of multi-chamber leadless pacing.
Identifiants
pubmed: 36417178
doi: 10.1007/s40119-022-00288-0
pii: 10.1007/s40119-022-00288-0
pmc: PMC9986180
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
21-33Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
Udo EO, Zuithoff NPA, Van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9:728–35.
pubmed: 22182495
doi: 10.1016/j.hrthm.2011.12.014
Wang Y, Hou W, Zhou C, et al. Meta-analysis of the incidence of lead dislodgement with conventional and leadless pacemaker systems. PACE Pacing Clin Electrophysiol. 2018;41:1365–71.
pubmed: 30066363
doi: 10.1111/pace.13458
Haghjoo M, Nikoo MH, Fazelifar AF, Alizadeh A, Emkanjoo Z, Sadr-Ameli MA. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace. 2007;9:328–32.
pubmed: 17369270
doi: 10.1093/europace/eum019
Tobin K, Stewart J, Westveer D, Frumin H. Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol. 2000;85:774–6.
pubmed: 12000060
doi: 10.1016/S0002-9149(99)00861-9
Cantillon DJ, Exner DV, Badie N, et al. Complications and health care costs associated with transvenous cardiac pacemakers in a nationwide assessment. JACC Clin Electrophysiol. 2017;3:1296–305.
pubmed: 29759627
doi: 10.1016/j.jacep.2017.05.007
Cantillon DJ, Dukkipati SR, Ip JH, et al. Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers. Heart Rhythm. 2018;15:1023–30.
pubmed: 29957188
doi: 10.1016/j.hrthm.2018.04.022
Spickler JW, Rasor NS, Kezdi P, Misra SN, Robins KE, LeBoeuf C. Totally self-contained intracardiac pacemaker. J Electrocardiol. 1970;3:325–31.
pubmed: 5517593
doi: 10.1016/S0022-0736(70)80059-0
Vardas P, Politopoulos C, Manios E, Parthenakis F, Tsagarkis C. A miniature pacemaker introduced intravenously and implanted endocardially: preliminary findings from an experimental study. Eur J Card Pacing Electrophysiol. 1991;1:27–33.
Takeuchi ES, Quattrini PJ, Greatbatch W. Lithium/silver vanadium oxide batteries for implantable defibrillators. Pacing Clin Electrophysiol. 1988;11:2035–9.
pubmed: 2463584
doi: 10.1111/j.1540-8159.1988.tb06346.x
Bock DC, Marschilok AC, Takeuchi KJ, Takeuchi ES. Batteries used to power implantable biomedical devices. Electrochim Acta. 2012;84:155–64.
doi: 10.1016/j.electacta.2012.03.057
Boveda S, Lenarczyk R, Haugaa KH, et al. Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey. Europace. 2018;20:555–9.
pubmed: 29360974
doi: 10.1093/europace/eux381
Reddy VY, Knops RE, Sperzel J, et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014;129:1466–71.
pubmed: 24664277
doi: 10.1161/CIRCULATIONAHA.113.006987
Knops RE, Tjong FVY, Neuzil P, et al. Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial. J Am Coll Cardiol. 2015;65:1497–504.
pubmed: 25881930
doi: 10.1016/j.jacc.2015.02.022
Reddy VY, Exner DV, Cantillon DJ, et al. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med. 2015;373:1125–35.
pubmed: 26321198
doi: 10.1056/NEJMoa1507192
Lakkireddy D, Knops R, Atwater B, et al. A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker. Heart Rhythm. 2017;14:1756–63.
pubmed: 28705736
doi: 10.1016/j.hrthm.2017.07.004
Ibrahim R, Khoury A, El-Chami MF. Leadless pacing: where we currently stand and what the future holds. Curr Cardiol Rep. 2022;1:1–8. https://doi.org/10.1007/s11886-022-01752-y .
Reddy VY, Exner DV, Doshi R, et al. Primary results on safety and efficacy from the LEADLESS II—phase 2 worldwide clinical trial. Clin Electrophysiol. 2022;8:115–7. https://doi.org/10.1016/j.jacep.2021.11.002 .
Ritter P, Group MTPS, Duray GZ, et al. Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J. 2015;36:2510–9. https://academic.oup.com/eurheartj/article/36/37/2510/2465991 . Accessed 2 Sep 2022.
Reynolds D, Duray GZ, Omar R, et al. A leadless intracardiac transcatheter pacing system. N Engl J Med. 2016;374:533–41.
pubmed: 26551877
doi: 10.1056/NEJMoa1511643
Duray GZ, Ritter P, El-Chami M, et al. Long-term performance of a transcatheter pacing system: 12-month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017;14:702–9.
pubmed: 28192207
doi: 10.1016/j.hrthm.2017.01.035
Roberts PR, Clementy N, Al Samadi F, et al. A leadless pacemaker in the real-world setting: the Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm. 2017;14:1375–9.
pubmed: 28502871
doi: 10.1016/j.hrthm.2017.05.017
El-Chami MF, Al-Samadi F, Clementy N, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical control. Heart Rhythm. 2018;15:1800–7.
pubmed: 30103071
doi: 10.1016/j.hrthm.2018.08.005
Tjong FVY, Knops RE, Udo EO, et al. Leadless pacemaker versus transvenous single-chamber pacemaker therapy: a propensity score-matched analysis. Heart Rhythm. 2018;15:1387–93.
pubmed: 29709576
doi: 10.1016/j.hrthm.2018.04.027
El-Chami MF, Soejima K, Piccini JP, et al. Incidence and outcomes of systemic infections in patients with leadless pacemakers: data from the Micra IDE study. PACE Pacing Clin Electrophysiol. 2019;42:1105–10.
pubmed: 31232461
doi: 10.1111/pace.13752
Hauser RG, Hayes DL, Kallinen LM, et al. Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective multicenter study. Heart Rhythm. 2007;4:154–60.
pubmed: 17275749
doi: 10.1016/j.hrthm.2006.10.009
Vamos M, Erath JW, Benz AP, Bari Z, Duray GZ, Hohnloser SH. Incidence of cardiac perforation with conventional and with leadless pacemaker systems: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2017;28:336–46.
pubmed: 27925339
doi: 10.1111/jce.13140
El-Chami MF, Johansen JB, Zaidi A, et al. Leadless pacemaker implant in patients with pre-existing infections: results from the Micra postapproval registry. J Cardiovasc Electrophysiol. 2019;30:569–74.
pubmed: 30661279
pmcid: 6850680
doi: 10.1111/jce.13851
El-Chami MF, Bonner M, Holbrook R, et al. Leadless pacemakers reduce risk of device-related infection: review of the potential mechanisms. Heart Rhythm. 2020;17:1393–7.
pubmed: 32247833
doi: 10.1016/j.hrthm.2020.03.019
Dar T, Akella K, Murtaza G, et al. Comparison of the safety and efficacy of Nanostim and Micra transcatheter leadless pacemaker (LP) extractions: a multicenter experience. J Interv Card Electrophysiol. 2020;57:133–40.
pubmed: 31907831
doi: 10.1007/s10840-019-00684-y
Li J, Hou WB, Cao MK, et al. Safety and efficacy of leadless pacemaker retrieval. J Cardiovasc Electrophysiol. 2019;30:1671–8.
pubmed: 31310416
doi: 10.1111/jce.14076
Bhatia NK, Kiani S, Merchant FM, et al. Life cycle management of Micra transcatheter pacing system: data from a high-volume center. J Cardiovasc Electrophysiol. 2021;32:484–90.
pubmed: 33251698
doi: 10.1111/jce.14825
Loring Z, North R, Hellkamp AS, et al. VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers. PACE Pacing Clin Electrophysiol. 2020;43:1461–6.
pubmed: 33085123
doi: 10.1111/pace.14100
Brignole M, Auricchio A, Baron-Esquivias G, et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2013;34:2281–329.
pubmed: 23801822
Razeghi O, Strocchi M, Lee A, et al. Tracking the motion of intracardiac structures aids the development of future leadless pacing systems. J Cardiovasc Electrophysiol. 2020;31:2431–9.
pubmed: 32639621
doi: 10.1111/jce.14657
Kiblboeck D, Reiter C, Kammler J, et al. Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers. J Cardiovasc Magn Reson. 2018;20:47.
pubmed: 29973228
pmcid: 6033226
doi: 10.1186/s12968-018-0469-4
Hála P, Neužil P, Keller J, et al. Quantification of artifacts during cardiac magnetic resonance in patients with leadless Micra pacemakers. J Cardiovasc Electrophysiol. 2021;32:1367–75.
pubmed: 33682228
doi: 10.1111/jce.14988
Kruse I, Arnman K, Conradson TB, Ryden L. A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing. Circulation. 1982;65:846–55.
pubmed: 7074746
doi: 10.1161/01.CIR.65.5.846
El-Chami MF, Bockstedt L, Longacre C, et al. Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up. Eur Heart J. 2022;43:1207–15. https://academic.oup.com/eurheartj/article/43/12/1207/6425620 . Accessed 3 May 2022.
Chinitz L, Ritter P, Khelae SK, et al. Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: results from the Micra atrioventricular feasibility studies. Heart Rhythm. 2018;15:1363–71.
pubmed: 29758405
doi: 10.1016/j.hrthm.2018.05.004
Garweg C, Splett V, Sheldon TJ, et al. Behavior of leadless AV synchronous pacing during atrial arrhythmias and stability of the atrial signals over time—results of the MARVEL Evolve subanalysis. PACE Pacing Clin Electrophysiol. 2019;42:381–7.
pubmed: 30687931
doi: 10.1111/pace.13615
Steinwender C, Khelae SK, Garweg C, et al. Atrioventricular synchronous pacing using a leadless ventricular pacemaker: results from the MARVEL 2 study. JACC Clin Electrophysiol. 2020;6:94–106.
pubmed: 31709982
doi: 10.1016/j.jacep.2019.10.017
Bereuter L, Gysin M, Kueffer T, et al. Leadless dual-chamber pacing: a novel communication method for wireless pacemaker synchronization. JACC Basic Transl Sci. 2018;3:813–23.
pubmed: 30623141
pmcid: 6314974
doi: 10.1016/j.jacbts.2018.07.009
Vatterott PJ, Eggen MD, Hilpisch KE, et al. Implant, performance, and retrieval of an atrial leadless pacemaker in sheep. Heart Rhythm. 2021;18:288–96.
pubmed: 33035647
doi: 10.1016/j.hrthm.2020.09.022
Knops RE, Olde Nordkamp LRA, Delnoy P-PHM, et al. Subcutaneous or transvenous defibrillator therapy. N Engl J Med. 2020;383:526–36.
pubmed: 32757521
doi: 10.1056/NEJMoa1915932
Tjong FVY, Brouwer TF, Smeding L, et al. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance. Europace. 2016;18:1740–7.
pubmed: 26941338
doi: 10.1093/europace/euv457
Tjong FVY, Brouwer TF, Koop B, et al. Acute and 3-month performance of a communicating leadless antitachycardia pacemaker and subcutaneous implantable defibrillator. JACC Clin Electrophysiol. 2017;3:1487–98.
pubmed: 29759829
doi: 10.1016/j.jacep.2017.04.002
Breeman KTN, Swackhamer B, Brisben AJ, et al. Long-term performance of a novel communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: a comprehensive preclinical study. Heart Rhythm. 2022;19:837–46.
pubmed: 35066181
doi: 10.1016/j.hrthm.2022.01.024
Fernández-Palacios G, García-Morán E, Sandín-Fuentes M, García-Granja P, Rubio J, San Román A. The utility of a combined synchronous atrioventricular leadless pacemaker and subcutaneous implantable cardiac defibrillator system in bilateral upper limb venous occlusion. Europace. 2020;23:814.
doi: 10.1093/europace/euaa332
Crozier I, O’Donnell D, et al. The extravascular implantable cardioverter-defibrillator: the pivotal study plan. J Cardiovasc Electrophysiol. 2021;32:2371–8.
pubmed: 34322918
pmcid: 9290824
doi: 10.1111/jce.15190
Wijesuriya N, Elliott MK, Mehta V, et al. Leadless left bundle branch area pacing in cardiac resynchronisation therapy: advances, challenges and future directions. Front Physiol. 2022;13: 898866.
pubmed: 35733988
pmcid: 9208327
doi: 10.3389/fphys.2022.898866
Auricchio A, Delnoy PP, Butter C, et al. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the Wireless Stimulation Endocardially for CRT (WiSE-CRT) study. Europace. 2014;16:681–8.
pubmed: 24497573
doi: 10.1093/europace/eut435
Reddy VY, Miller MA, Neuzil P, et al. Cardiac resynchronization therapy with wireless left ventricular endocardial pacing: the SELECT-LV study. J Am Coll Cardiol. 2017;69:2119–29.
pubmed: 28449772
doi: 10.1016/j.jacc.2017.02.059
Sieniewicz BJ, Behar JM, Gould J, et al. Guidance for optimal site selection of a leadless left ventricular endocardial electrode improves acute hemodynamic response and chronic remodeling. JACC Clin Electrophysiol. 2018;4:860–8.
pubmed: 30025684
doi: 10.1016/j.jacep.2018.03.011
Sieniewicz BJ, Betts TR, James S, et al. Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: a multicenter international registry of the WiSE-CRT pacing system. Heart Rhythm. 2020;17:1291–7.
pubmed: 32165181
pmcid: 7397503
doi: 10.1016/j.hrthm.2020.03.002
Wijesuriya N, Elliott MK, Mehta V, et al. Leadless left ventricular endocardial pacing for cardiac resynchronization therapy: a systematic review and meta-analysis. Heart Rhythm. 2022;19:1176–83.
pubmed: 35189383
doi: 10.1016/j.hrthm.2022.02.018
Sieniewicz BJ, Gould JS, Rimington HM, Ioannou N, Rinaldi CA. Transseptal delivery of a leadless left ventricular endocardial pacing electrode. JACC Clin Electrophysiol. 2017;3:1333–5. https://doi.org/10.1016/j.jacep.2017.04.020 .
Okabe T, Hummel JD, Bank AJ, et al. Leadless left ventricular stimulation with WiSE-CRT System—initial experience and results from phase I of SOLVE-CRT Study (nonrandomized, roll-in phase). Heart Rhythm. 2022;19:22–9.
pubmed: 34332966
doi: 10.1016/j.hrthm.2021.06.1195
Singh JP, Walsh MN, Kubo SH, et al. Modified design of stimulation of the left ventricular endocardium for cardiac resynchronization therapy in nonresponders, previously untreatable and high-risk upgrade patients (SOLVE-CRT) trial. Am Heart J. 2021;235:158–62. https://pubmed.ncbi.nlm.nih.gov/33596412/ . Accessed 3 May 2022.
Carabelli A, Jabeur M, Jacon P, et al. European experience with a first totally leadless cardiac resynchronization therapy pacemaker system. Europace. 2021;23:740–7.
pubmed: 33313789
doi: 10.1093/europace/euaa342
Sidhu BS, Gould J, Porter B, et al. Completely leadless cardiac resynchronization defibrillator system. JACC Clin Electrophysiol. 2020;6:588–9.
pubmed: 32439047
doi: 10.1016/j.jacep.2020.02.012
Elliott MK, Sidhu BS, Mehta VS, Gould J, Martic D, Rinaldi CA. The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems. Heart Rhythm Case Rep. 2021;7:628–632. https://pubmed.ncbi.nlm.nih.gov/34552857/ . Accessed 3 May 2022.
Teigeler T, Kolominsky J, Vo C, et al. Intermediate-term performance and safety of His-bundle pacing leads: a single-center experience. Heart Rhythm. 2021;18:743–9.
pubmed: 33418127
doi: 10.1016/j.hrthm.2020.12.031
Padala SK, Ellenbogen KA. Left bundle branch pacing is the best approach to physiological pacing. Heart Rhythm O2. 2020;1:59–67. http://www.heartrhythmopen.com/article/S266650182030009X/fulltext . Accessed 17 Jan 2022.
Zhang W, Huang J, Qi Y, et al. Cardiac resynchronization therapy by left bundle branch area pacing in patients with heart failure and left bundle branch block. Heart Rhythm. 2019;16:1783–90.
pubmed: 31513945
doi: 10.1016/j.hrthm.2019.09.006
Elliott MK, Jacon P, Sidhu BS, et al. Technical feasibility of leadless left bundle branch area pacing for cardiac resynchronization: a case series. Eur Heart J Case Rep. 2021;5. https://academic.oup.com/ehjcr/article/5/11/ytab379/6374927 . Accessed 17 Jan 2022.
Franzina N, Zurbuchen A, Zumbrunnen A, et al. A miniaturized endocardial electromagnetic energy harvester for leadless cardiac pacemakers. PLoS One. 2020;15:e0239667.
pubmed: 32986751
pmcid: 7521684
doi: 10.1371/journal.pone.0239667
Zurbuchen A, Haeberlin A, Bereuter L, et al. The Swiss approach for a heartbeat-driven lead- and batteryless pacemaker. Heart Rhythm. 2017;14:294–9.
pubmed: 27756706
doi: 10.1016/j.hrthm.2016.10.016